Catalyst Wire Dossier Catalyst Wire Dossier

Clindamycin phosphate / benzoyl peroxide topical gel 1.2%/2.5%

clindamycin phosphate; benzoyl peroxide · Padagis LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clindamycin phosphate / benzoyl peroxide topical gel 1.2%/2.5%, covering 2021-01-20 to 2021-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris [Phase 3]

See pricing